Related Experiment Video
Updated: Jun 24, 2026

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli
Published on: March 24, 2023
Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing
Yoon Soo Park1, Sunmi Yoo, Mi-Ran Seo
1Department of Internal Medicine, Gachon University, Gil Medical Center, 1198 Guwol-dong, Namdong-gu, Incheon 405-760, South Korea.
Abstract:
A case-control study was performed with the objective of analysing risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase (plasmid AmpC)-producing Enterobacteriaceae. All patients infected with plasmid AmpC-producing Enterobacteriaceae in two tertiary care hospitals from December 2006 to August 2007 were included. Plasmid AmpC enzymes were characterised by isoelectric focusing, enzyme inhibition assay and enzyme-specific polymerase chain reaction. A total of 30 patients (20 with Klebsiella pneumoniae and 10 with Escherichia coli) were recruited prospectively. CMY-2 and DHA-1 were the most common plasmid AmpC in E. coli and K. pneumoniae, respectively. An independent risk factor for infection with plasmid AmpC-producing Enterobacteriaceae was the use of an oxyimino-cephalosporin within 1 month of plasmid AmpC infection [adjusted odds ratio (aOR), 10.8, 95% confidence interval (CI), 1.6-75.4; P=0.016], with the use of a urinary catheter showing borderline significance (aOR, 6, 95% CI 0.93-38.4; P=0.06). An independent risk factor for treatment failure at 72 h was infection due to plasmid AmpC-producing Enterobacteriaceae (aOR, 9.78, 95% CI 1.34-71.17; P=0.02). These results suggest that infections caused by plasmid AmpC-producing isolates significantly increase treatment failure at 72 h and that prior use of an oxyimino-cephalosporin is a risk factor for infections caused by plasmid AmpC-producing Enterobacteriaceae.
Insights
Infections by plasmid-mediated AmpC beta-lactamase (plasmid AmpC)-producing Enterobacteriaceae are linked to increased treatment failure. Prior use of oxyimino-cephalosporins is a significant risk factor for these infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Plasmid-mediated AmpC beta-lactamases (plasmid AmpC) are increasingly recognized in Enterobacteriaceae.
- Understanding risk factors and clinical features of plasmid AmpC-producing Enterobacteriaceae infections is crucial for effective management.
Purpose of the Study:
- To analyze risk factors and clinical features of infections caused by plasmid AmpC-producing Enterobacteriaceae.
- To identify independent risk factors for infection and treatment failure.
Main Methods:
- A case-control study was conducted in two tertiary care hospitals.
- Patients infected with plasmid AmpC-producing Enterobacteriaceae were prospectively recruited.
- Plasmid AmpC enzymes were characterized using isoelectric focusing, enzyme inhibition assays, and polymerase chain reaction.
Main Results:
- Twenty Klebsiella pneumoniae and ten Escherichia coli isolates were analyzed.
- CMY-2 and DHA-1 were the most common plasmid AmpC types.
- Prior oxyimino-cephalosporin use (aOR, 10.8) and urinary catheter use (aOR, 6) were risk factors for infection.
- Infection with plasmid AmpC-producing Enterobacteriaceae was an independent risk factor for treatment failure at 72 hours (aOR, 9.78).
Conclusions:
- Infections caused by plasmid AmpC-producing Enterobacteriaceae significantly increase the risk of treatment failure.
- Prior use of oxyimino-cephalosporins is a significant risk factor for acquiring these infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Pneumonia I: Introduction
